{
  "Variants Include": [
    {
      "Gene": "PINK1",
      "variants": [
        {
          "HGVS": "NM_032409.3:c.1311G>A",
          "cDNA Change": {
            "transcript": "NM_032409.3",
            "ref": "G",
            "alt": "A",
            "position": "1311"
          },
          "Protein Change": {
            "ref": "W",
            "alt": "X",
            "position": "437"
          },
          "Description in input context": "p.W437X"
        }
      ]
    },
    {
      "Gene": "ND5",
      "variants": [
        {
          "HGVS": "NC_012920.1:m.12397A>G",
          "cDNA Change": {
            "transcript": "NC_012920.1",
            "ref": "A",
            "alt": "G",
            "position": "12397"
          },
          "Protein Change": {
            "ref": "T",
            "alt": "A",
            "position": "21"
          },
          "Description in input context": "m.12397A>G (p.T21A)"
        }
      ]
    },
    {
      "Gene": "ND6",
      "variants": [
        {
          "HGVS": "NC_012920.1:m.14319T>C",
          "cDNA Change": {
            "transcript": "NC_012920.1",
            "ref": "T",
            "alt": "C",
            "position": "14319"
          },
          "Protein Change": {
            "ref": "N",
            "alt": "D",
            "position": "119"
          },
          "Description in input context": "m.14319T>C (p.N119D)"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's Disease",
    "MONDO": "MONDO:0005180"
  },
  "Experiment Method": [
    {
      "Assay Method": "Quantitative PCR for mtDNA/nDNA Ratio",
      "Material used": {
        "Material Source": "Patient Derived Material",
        "Material Name": "Dermal Fibroblasts",
        "Description": "Dermal fibroblasts were isolated from explanted patient's biopsy specimen."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_032409.3:c.1311G>A",
          "Conclusion": "Normal",
          "Molecular Effect": "N.D.",
          "Result Description": "No variation in mtDNA copy number was observed in patient's fibroblasts for the PINK1 mutation."
        },
        {
          "Variant": "NC_012920.1:m.12397A>G",
          "Conclusion": "Normal",
          "Molecular Effect": "N.D.",
          "Result Description": "No variation in mtDNA copy number was observed in patient's fibroblasts for the ND5 mutation."
        },
        {
          "Variant": "NC_012920.1:m.14319T>C",
          "Conclusion": "Normal",
          "Molecular Effect": "N.D.",
          "Result Description": "No variation in mtDNA copy number was observed in patient's fibroblasts for the ND6 mutation."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Average of three different measurements."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "N.D."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Adult normal human dermal fibroblasts (NHDF) were used as control."
      },
      "Basic negative control": {
        "Basic negative control": "No",
        "Description": "N.D."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "No",
        "Counts": "0"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "No",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Comparable mtDNA copy number to control (around 10^3 mtDNA copies/cell).",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Significant deviation from control mtDNA copy number.",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "mtDNA Sequencing",
      "Material used": {
        "Material Source": "Patient Derived Material",
        "Material Name": "Dermal Fibroblasts and Blood Sample",
        "Description": "DNA extracted from patient's fibroblasts and blood sample for mtDNA sequencing."
      },
      "Readout type": "Qualitative",
      "Readout description": [
        {
          "Variant": "NM_032409.3:c.1311G>A",
          "Conclusion": "N.D.",
          "Molecular Effect": "N.D.",
          "Result Description": "PINK1 mutation was not directly assessed in mtDNA sequencing."
        },
        {
          "Variant": "NC_012920.1:m.12397A>G",
          "Conclusion": "Abnormal",
          "Molecular Effect": "N.D.",
          "Result Description": "Homoplasmic mutation m.12397A>G (p.T21A) in ND5 gene detected in patient's fibroblasts and blood sample."
        },
        {
          "Variant": "NC_012920.1:m.14319T>C",
          "Conclusion": "Abnormal",
          "Molecular Effect": "N.D.",
          "Result Description": "Homoplasmic mutation m.14319T>C (p.N119D) in ND6 gene detected in patient's fibroblasts and blood sample."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Confirmed in a different batch of originally isolated fibroblasts and blood sample."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "N.D."
      },
      "Basic positive control": {
        "Basic positive control": "No",
        "Description": "N.D."
      },
      "Basic negative control": {
        "Basic negative control": "No",
        "Description": "N.D."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "No",
        "Counts": "0"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "No",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "No mutations or known polymorphisms compared to Cambridge sequence.",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Presence of unreported single nucleotide changes resulting in amino acid substitution.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Enzymatic Assay for NADH:ubiquinone Oxidoreductase Activity",
      "Material used": {
        "Material Source": "Patient Derived Material",
        "Material Name": "Dermal Fibroblasts",
        "Description": "Ultrasound treated fibroblasts suspended for enzymatic assay."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_032409.3:c.1311G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "partial loss-of-function",
          "Result Description": "PINK1 mutation associated with altered enzymatic parameters in complex I."
        },
        {
          "Variant": "NC_012920.1:m.12397A>G",
          "Conclusion": "Abnormal",
          "Molecular Effect": "N.D.",
          "Result Description": "ND5 mutation associated with almost fivefold decrease in apparent Km for substrates and 26% inhibition of Vmax with NADH."
        },
        {
          "Variant": "NC_012920.1:m.14319T>C",
          "Conclusion": "Abnormal",
          "Molecular Effect": "N.D.",
          "Result Description": "ND6 mutation associated with almost fivefold decrease in apparent Km for substrates and 26% inhibition of Vmax with NADH."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "N.D."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Averages of two measurements at each substrate concentration."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Control fibroblasts (NHDF) used for comparison."
      },
      "Basic negative control": {
        "Basic negative control": "No",
        "Description": "N.D."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "No",
        "Counts": "0"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "No",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "Least square analysis of datasets for Lineweaver-Burk plots."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Enzymatic activity comparable to control fibroblasts (NHDF).",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Significant decrease in Km or Vmax compared to control.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Confocal Microscopy for Mitochondrial Superoxide Production",
      "Material used": {
        "Material Source": "Patient Derived Material",
        "Material Name": "Dermal Fibroblasts",
        "Description": "Cells cultured at low density on fibronectin coated dishes."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_032409.3:c.1311G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "partial loss-of-function",
          "Result Description": "Significant twofold increase in superoxide production in patient's fibroblasts with PINK1 mutation."
        },
        {
          "Variant": "NC_012920.1:m.12397A>G",
          "Conclusion": "Abnormal",
          "Molecular Effect": "N.D.",
          "Result Description": "ND5 mutation associated with enhanced constitutive production of superoxide anion radical."
        },
        {
          "Variant": "NC_012920.1:m.14319T>C",
          "Conclusion": "Abnormal",
          "Molecular Effect": "N.D.",
          "Result Description": "ND6 mutation associated with enhanced constitutive production of superoxide anion radical."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Representative of four independent analyses."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "N.D."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Control fibroblasts (NHDF) used for comparison."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Pre-treatment with diphenyleneiodinium (DPI) to inhibit complex I."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "No",
        "Counts": "0"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "No",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "Student's t test with p < 0.05."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Fluorescence intensity comparable to control fibroblasts (NHDF).",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Significant increase in fluorescence intensity compared to control (twofold increase).",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Two-Dimensional Gel Analysis and Western Blotting",
      "Material used": {
        "Material Source": "Patient Derived Material",
        "Material Name": "Dermal Fibroblasts",
        "Description": "Mitoplasts from NHDFs or patient's fibroblasts for gel analysis."
      },
      "Readout type": "Qualitative",
      "Readout description": [
        {
          "Variant": "NM_032409.3:c.1311G>A",
          "Conclusion": "Normal",
          "Molecular Effect": "N.D.",
          "Result Description": "No detectable change in expression of oxidative phosphorylation complexes for PINK1 mutation."
        },
        {
          "Variant": "NC_012920.1:m.12397A>G",
          "Conclusion": "Normal",
          "Molecular Effect": "N.D.",
          "Result Description": "No detectable change in expression of oxidative phosphorylation complexes for ND5 mutation."
        },
        {
          "Variant": "NC_012920.1:m.14319T>C",
          "Conclusion": "Normal",
          "Molecular Effect": "N.D.",
          "Result Description": "No detectable change in expression of oxidative phosphorylation complexes for ND6 mutation."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Representative of three independent assays for gel analysis and repeated twice for western blotting."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "N.D."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Control fibroblasts (NHDF) used for comparison."
      },
      "Basic negative control": {
        "Basic negative control": "No",
        "Description": "N.D."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "No",
        "Counts": "0"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "No",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Expression levels of OXPHOS complexes comparable to control fibroblasts (NHDF).",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Significant deviation in expression levels of OXPHOS complexes compared to control.",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}